Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Kamada Ltd (KMDA)

Kamada Ltd (KMDA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 348,369
  • Shares Outstanding, K 44,520
  • Annual Sales, $ 127,190 K
  • Annual Income, $ 22,250 K
  • 60-Month Beta 1.24
  • Price/Sales 2.73
  • Price/Cash Flow 12.97
  • Price/Book 2.09

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 0.12
  • Number of Estimates 2
  • High Estimate 0.12
  • Low Estimate 0.11
  • Prior Year 0.15
  • Growth Rate Est. (year over year) -20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.54 +19.65%
on 05/19/20
9.75 -19.74%
on 05/22/20
+0.38 (+5.17%)
since 05/04/20
3-Month
4.40 +77.84%
on 03/16/20
9.75 -19.74%
on 05/22/20
+2.11 (+37.04%)
since 03/04/20
52-Week
4.40 +77.84%
on 03/16/20
9.75 -19.74%
on 05/22/20
+2.22 (+39.66%)
since 06/04/19

Most Recent Stories

More News
Kamada (KMDA) Q1 Earnings and Revenues Top Estimates

Kamada (KMDA) delivered earnings and revenue surprises of 62.50% and 8.17%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

KMDA : 7.82 (+0.32%)
Kamada Reports First Quarter 2020 Financial Results and Highlights Recent Corporate Progress

Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a plasma-derived biopharmaceutical company, today announced financial results for the three months ended March 31, 2020.

KMDA : 7.82 (+0.32%)
Kamada to Announce First Quarter Ended March 31, 2020 Financial Results and Host Conference Call on May 18, 2020

Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived biopharmaceutical company, today announced that it will release financial results for the first quarter ended March 31, 2020, prior to the open of the...

KMDA : 7.82 (+0.32%)
Analysts Estimate Kamada (KMDA) to Report a Decline in Earnings: What to Look Out for

Kamada (KMDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

KMDA : 7.82 (+0.32%)
Leading Biotech Companies Kedrion Biopharma of Italy and Kamada Ltd. of Israel Announce Global Collaboration to Speed New Anti-COVID Plasma-Based Treatment

Two innovative bio-pharma companies specialized in plasma-derived therapeutics - Kedrion Biopharma of Italy and Kamada Ltd. of Israel - have announced that they are joining forces for the development,...

KMDA : 7.82 (+0.32%)
Kamada and Kedrion Biopharma Announce Global Collaboration for the Development, Manufacturing and Distribution of a Plasma-Derived Anti-SARS-CoV-2 (COVID-19) Polyclonal Immunoglobulin Product

-- Kedrion is Responsible for the Collection and Supply of Plasma from Convalescent COVID-19 Patients, Support of Clinical Development and Distribution in the U.S., Europe, Australia, and S. Korea

KMDA : 7.82 (+0.32%)
LYFT, SIX, VIR, RDHL and KMDA as Zacks Bull and Bear of the Day

LYFT, SIX, VIR, RDHL and KMDA as Zacks Bull and Bear of the Day

KMDA : 7.82 (+0.32%)
SIX : 25.17 (-0.55%)
RDHL : 6.93 (-0.57%)
VIR : 34.01 (+1.77%)
LYFT : 36.08 (+4.75%)
Weekly Biotech Update After WHO Declares Coronavirus a Pandemic

Several pharma/companies are working to develop a treatment for novel coronavirus as WHO declares Covid-19 a pandemic.

RHHBY : 43.3000 (-1.46%)
LLY : 150.71 (-1.19%)
ABBV : 93.04 (+2.37%)
KMDA : 7.82 (+0.32%)
3 Small Biotechs Provide Coronavirus Drug Development Updates

Several drug/biotech companies are working on making new antibodies, drugs, and vaccines to prevent and treat COVID-19.

JNJ : 146.73 (-1.29%)
GILD : 77.54 (+4.22%)
MRNA : 60.59 (+1.17%)
NVAX : 44.66 (+0.93%)
KMDA : 7.82 (+0.32%)
INO : 11.88 (-4.42%)
RDHL : 6.93 (-0.57%)
VIR : 34.01 (+1.77%)
Kamada Provides Update on Progress Related to its Proprietary Hyper-Immunoglobulin (IgGs) Platform Technology including its Commercial Anti-Rabies IgG and its Pipeline Products Anti-Corona (COVID-19) and Anti-Zika IgGs

Kamada Ltd. (NASDAQ & TASE: KMDA), a commercial-stage plasma-derived biopharmaceutical company, today provided an update on progress related to its proprietary hyper-immunoglobulin (IgGs) product portfolio...

KMDA : 7.82 (+0.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade KMDA with:

Business Summary

Kamada Ltd. is a biopharmaceutical company. It develops, produces and markets therapeutics based on chromatographic purification technology. The company offers bio-therapeutics for specialty proteins, specific immunoglobulins and other prescription medicines. Kamada Ltd. is headquartered in Ness Ziona,...

See More

Key Turning Points

2nd Resistance Point 8.39
1st Resistance Point 8.11
Last Price 7.82
1st Support Level 7.67
2nd Support Level 7.52

See More

52-Week High 9.75
Last Price 7.82
Fibonacci 61.8% 7.71
Fibonacci 50% 7.07
Fibonacci 38.2% 6.44
52-Week Low 4.40

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar